Literature DB >> 24806178

Prevention of preterm parturition.

Jay D Iams.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24806178     DOI： 10.1056/NEJMc1402822

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth.

Authors:  Steve N Caritis; Maisa N Feghali; William A Grobman; Dwight J Rouse
Journal:  Semin Perinatol       Date:  2016-04-19       Impact factor: 3.300

2.  Progesterone Receptor-Mediated Actions Regulate Remodeling of the Cervix in Preparation for Preterm Parturition.

Authors:  Michael A Kirby; Anne C Heuerman; Melisa Custer; Abigail E Dobyns; Ryan Strilaeff; Kathleen N Stutz; Jaclyn Cooperrider; Joseph G Elsissy; Steven M Yellon
Journal:  Reprod Sci       Date:  2016-05-27       Impact factor: 3.060

Review 3.  Can We Prevent Bronchopulmonary Dysplasia?

Authors:  Judy L Aschner; Eduardo H Bancalari; Cindy T McEvoy
Journal:  J Pediatr       Date:  2017-10       Impact factor: 4.406

4.  Toll-Like Receptor-4 Antagonist (+)-Naltrexone Protects Against Carbamyl-Platelet Activating Factor (cPAF)-Induced Preterm Labor in Mice.

Authors:  Hanan H Wahid; Peck Yin Chin; David J Sharkey; Kerrilyn R Diener; Mark R Hutchinson; Kenner C Rice; Lachlan M Moldenhauer; Sarah A Robertson
Journal:  Am J Pathol       Date:  2020-02-18       Impact factor: 4.307

5.  Maternal tea consumption and the risk of preterm delivery in urban China: a birth cohort study.

Authors:  Lei Huang; Catherine Lerro; Tao Yang; Jing Li; Jie Qiu; Weitao Qiu; Xiaochun He; Hongmei Cui; Ling Lv; Ruifeng Xu; Xiaoying Xu; Huang Huang; Qing Liu; Yawei Zhang
Journal:  BMC Public Health       Date:  2016-05-31       Impact factor: 3.295

6.  Novel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birth.

Authors:  Peck Yin Chin; Camilla L Dorian; Mark R Hutchinson; David M Olson; Kenner C Rice; Lachlan M Moldenhauer; Sarah A Robertson
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

7.  The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk.

Authors:  Lindsay M Kindinger; Phillip R Bennett; Yun S Lee; Julian R Marchesi; Ann Smith; Stefano Cacciatore; Elaine Holmes; Jeremy K Nicholson; T G Teoh; David A MacIntyre
Journal:  Microbiome       Date:  2017-01-19       Impact factor: 14.650

8.  Do the interactions between coital frequency, cervical length, and urogenital infection affect obstetric outcomes?

Authors:  Yiğit Çakıroğlu; Şeyda Çalışkan; Emek Doğer; Şule Yıldırım Köpük; Devrim Dündar; Eray Çalışkan
Journal:  Turk J Obstet Gynecol       Date:  2015-06-15

Review 9.  Targeting Toll-like receptor-4 to tackle preterm birth and fetal inflammatory injury.

Authors:  Sarah A Robertson; Mark R Hutchinson; Kenner C Rice; Peck-Yin Chin; Lachlan M Moldenhauer; Michael J Stark; David M Olson; Jeffrey A Keelan
Journal:  Clin Transl Immunology       Date:  2020-04-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.